Jain, Rakesh K.
Harvard University · Massachusetts General Hospital · Center for Systems Biology
7 papers on CoChatORCID 0000-0001-7571-3548
Most cited papers
- Verified
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer
Cancer Cells and MetastasisTGF-β signaling in diseases
Cited by 3,863
- Verified
Solid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology
Cellular Mechanics and InteractionsMathematical Biology Tumor Growth
Cited by 859
- Verified
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Reeves, J. W., Mohan, R., Drokhlyansky, E., Van Wittenberghe, N., Ashenberg, O., et al. (2022) · Nature Genetics
Pancreatic and Hepatic Oncology ResearchSingle-cell and spatial transcriptomics
Cited by 426
- Verified
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Incio, J., Ligibel, J. A., McManus, D. T., Suboj, P., Jung, K., Kawaguchi, K., Pinter, M., Babykutty, S., Chin, S. M., Vardam, T. D., et al. (2018) · Science Translational Medicine
Angiogenesis and VEGF in CancerLymphatic System and Diseases
Cited by 222
- Verified
Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade
Gomes-Santos, I. L., Amoozgar, Z., Kumar, A. S., Ho, W. W., Roh, K., Talele, N. P., Curtis, H., Kawaguchi, K., Jain, R. K., & Fukumura, D. (2021) · Cancer Immunology Research
Cancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune Response
Cited by 181
- Verified
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Jung, K., Heishi, T., Khan, O. F., Kowalski, P. S., Incio, J., Rahbari, N. N., Chung, E., Clark, J. W., Willett, C. G., Luster, A. D., et al. (2017) · Journal of Clinical Investigation
Immune cells in cancerAngiogenesis and VEGF in Cancer
Cited by 164
- Verified
Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation
Zlotecki, R. A., Baxter, L. T., Boucher, Y., & Jain, R. K. (1995) · Microvascular Research
Angiogenesis and VEGF in CancerMathematical Biology Tumor Growth
Cited by 91
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free